                               SEQUENCE LISTING

<110>  THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE 
       SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
 
<120> SINGLE-CELL PROFILING OF CHROMATIN OCCUPANCY AND RNA SEQUENCING

<130> 058361-510001WO

<140> PCT/US2021/058809
<141> 2021-11-10

<150> 63/111,951
<151> 2020-11-10

<160> 13    

<170> PatentIn version 3.5

<210> 1
<211> 28
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 1
agaaccatgt cgtcagtgtc cccccccc                                          28


<210> 2
<211> 64
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (23)..(30)
<223> a, c, t, g, unknown or other

<400> 2
acactgacga catggttcta cannnnnnnn agatcggaag agcacacgtc tgaactccag       60

tcac                                                                    64


<210> 3
<211> 31
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
tgtagaacca tgtcgtcagt gtcccccccc c                                      31


<210> 4
<211> 31
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
gatcggaaga gcgtcgtgta gggaaagagt g                                      31


<210> 5
<211> 29
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 5
tctttcccta cacgacgctc ttccgatct                                         29


<210> 6
<211> 58
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer


<220>
<221> modified_base
<222> (23)..(28)
<223> a, c, t, g, unknown or other

<400> 6
tacggtagca gagacttggt ctnnnnnngt gactggagtt cagacgtgtg ctcttccg         58


<210> 7
<211> 60
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer


<220>
<221> modified_base
<222> (30)..(37)
<223> a, c, t, g, unknown or other

<400> 7
aatgatacgg cgaccaccga gatctacacn nnnnnnnaca ctctttccct acacgacgct       60


<210> 8
<211> 35
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer


<220>
<221> modified_base
<222> (1)..(6)
<223> a, c, t, g, unknown or other

<220>
<221> modified_base
<222> (35)..(35)
<223> a, c, t, g, unknown or other

<400> 8
nnnnnngagc gttttttttt tttttttttt tttvn                                  35


<210> 9
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 9
agaaccatgt cgtcagtgt                                                    19


<210> 10
<211> 56
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 10
acactgacga catggttcta caagatcgga agagcacacg tctgaactcc agtcac           56


<210> 11
<211> 52
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 11
aatgatacgg cgaccaccga gatctacaca cactctttcc ctacacgacg ct               52


<210> 12
<211> 46
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 12
caagcagaag acggcatacg agattacggt agcagagact tggtct                      46


<210> 13
<211> 31
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 13
gatcggaaga gcgtcgtgta gggaaagagt g                                      31


